Participant attitudes toward returning individual results from CADASIL research
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
INTRODUCTION
Neurodegenerative research identifies biomarkers to confirm presence of disease and inform about risk for clinical symptoms. Expert guidance advises caution about disclosing individual research results (IRR), but participant interest remains high even when IRR may not inform individual prognosis. Existing studies of stakeholder attitudes emphasize Alzheimer’s disease (AD) biomarkers. We explore participant attitudes toward IRR from the United States CADASIL Consortium (USCC), an observational study of Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL), the most heritable form of vascular dementia.
METHODS
Since CADASIL research participant attitudes are unstudied and AD-focused guidelines for IRR may not generalize to populations with dominantly inherited conditions, we surveyed USCC participants using three 5-point Likert items and one open-ended question. Descriptive statistics were analyzed for Likert items. The distribution of responses to one item was directly compared to an AD participant survey. Open-ended responses underwent qualitative content analysis.
RESULTS
We received 152 responses. The highest-rated reason to return IRR was “learn about my disease and its predicted course”. The highest-rated IRR were imaging/MRI scans and cognitive testing. Hypothetical negative outcomes were rated as a little to somewhat concerning. USCC respondents rated reasons to return IRR higher than AD counterparts, with statistically significant differences for seven of eight items. In open-ended responses, the most frequent code was “IRR return will help improve my health and well-being”.
DISCUSSION
Most respondents expressed support for disclosure upon participant request. These findings could inform IRR guidance for CADASIL and other disorders and investigations of personal utility.
